According to The Times of India, Ganesh Dongre, Senior Manager - Technical Research at Anand Rathi Shares and Stock Brokers Limited, has issued stock recommendations for September 16, 2026. The expert has identified PN Gadgil Jewellers and Mankind Pharma as top stock picks for the day, along with BEML as part of his recommendations. Latest reports from Live Mint confirm that market experts including Sumeet Bagadia of Choice Broking, Ganesh Dongre, and Shiju Koothupalakkal from Prabhudas Lilladher have recommended seven buy-or-sell stocks for intraday trading, including Prime Focus Ltd, ACME Solar Holdings Ltd, PN Gadgil Jewellers Ltd, Mankind Pharma Ltd, BEML Ltd, FDC Ltd, and Hatsun Agro Products Ltd.
As reported by The Times of India, PN Gadgil Jewellers is showing a positive technical setup on the daily chart with a trendline breakout visible in the ₹590–610 zone, indicating improving price structure. The stock is recommended for buy at ₹61 with a stop loss at ₹580 and target prices of ₹650 and ₹670. Latest trading recommendations from Live Mint suggest buy at ₹61 with the same stop loss and target parameters. The MACD indicator is moving into an oversold zone, which could support a potential momentum recovery in upcoming sessions.
According to The Times of India, Mankind Pharma is currently showing a constructive technical setup with the stock witnessing a strong recovery from lower levels and sustaining above its important short- and medium-term moving averages. The stock is recommended for buy at ₹2,280 with a stop loss at ₹2,200 and target prices of ₹3,380 and ₹2,450. Latest reports from Live Mint confirm the stock recommendation with buy at ₹2,280 and the same target and stop loss parameters. The stock is approaching a trendline drawn from its previous lows, with the ₹2,230–2,250 zone acting as an important support area.
As reported by The Times of India, for PN Gadgil Jewellers, traders who are already holding the stock can continue to hold, while existing positions may consider adding on dips around the ₹600–620 zone, subject to the stock sustaining above the breakout area. On the upside, ₹605–670 remains the immediate resistance zone, and a decisive close above ₹630 could further strengthen the bullish momentum. For Mankind Pharma, the stock is approaching the trendline resistance zone, with the ₹2,230–2,250 zone providing crucial support levels. Latest trading guidance from Live Mint suggests specific entry points and risk management levels for both stocks.
